The largest database of trusted experimental protocols

28 protocols using e coli lps

1

Immune Cell Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDCs and macrophages were incubated at 5 × 105/mL (neutrophils at 2.5 × 106/mL) with either 100 μg/mL curdlan (Sigma Aldrich), 500 ng/mL ultrapure E. coli LPS (Invivogen), or LPS + 3 mM extracellular ATP (Sigma Aldrich) added in the last hour of incubation. All cells were incubated at 37°C with 5% CO2.
+ Open protocol
+ Expand
2

Measuring ATP-induced Calcium Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated in a black-sided, optically clear flat bottom 96-well plate (Corning). PI (Alfa Aesar) was added to each well at 1:10,000 dilution in PBS. Cells were incubated in the Biotek Cytation-5 instrument at 37°C with 5% CO2. Red fluorescence reads at 590/640nm were measured every 1 minute for 5 minutes for background measurement before adding stimulation. Duplicate wells of cells were primed with 500 ng/mL E. coli LPS (Invivogen) or 100 μg/mL curdlan (Sigma Aldrich) for 6 hours. Three mM extracellular ATP (Sigma Aldrich) was added to LPS primed cells in the last hour of incubation in the LPS+ATP conditions. Fluorescence measurements were taken at 1-minute intervals throughout stimulation.
+ Open protocol
+ Expand
3

Immune Cell Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
BMDCs and macrophages were incubated at 5 × 105/mL (neutrophils at 2.5 × 106/mL) with either 100 μg/mL curdlan (Sigma Aldrich), 500 ng/mL ultrapure E. coli LPS (Invivogen), or LPS + 3 mM extracellular ATP (Sigma Aldrich) added in the last hour of incubation. All cells were incubated at 37°C with 5% CO2.
+ Open protocol
+ Expand
4

B Cell Stimulation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were sacrificed by CO2 inhalation according to a CWRU-approved IACUC protocol, and blood was obtained via cardiac blood draw into 3.2% sodium citrate to prevent coagulation. Plasma was generated from blood by taking the liquid fraction following centrifugation at 2500 x g for 15 minutes. B cells were obtained as described and plated in round-bottom 96-well plates at a density of 100,000 cells/well. The cells were stimulated by the addition of 100 ng/mL anti-CD40 (Clone 1C10; eBioscience) and 1 ng/mL E. coli LPS (Invivogen) to the media, and incubated for 7 days prior to media harvest.
+ Open protocol
+ Expand
5

Investigating Inflammasome Modulators in Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow derived macrophages (BMDM) were prepared as previously described52 (link). BMDM were stimulated with 500 ng/ml E. coli LPS (Invivogen, CA USA) and 3 h later treated with either 5 mM ATP (Sigma, MO USA), 10 μM nigericin (Enzo Life Science, INC., NY USA), or 130 μg/mL alum (Sigma) stimulation for NLRP3 inflammasome, 400 ng/ml poly(dA:dT) (Invivogen) for AIM2 inflammasome, and Salmonella Typhimurium IR715 and ΔfljB/fliC (MOI 5) for NLRC4 inflammasome activation34 (link). BMDM were treated with Quercetin, naringenin, or silymarin at the doses of 20 and 100 μM, 30 min before the signal-2 (ATP, nigericin, e.t.c.) stimulation. Nlrp3A350/A350 BMDM were primed with LPS (500 ng/mL) and treated with Quercetin 1 hour after priming. Supernatants were collected and assessed for IL-1β and TNF-α concentration by ELISA (eBiosciences).
Quercetin, naringenin, and silymarin were purchased from Sigma. For in vitro experiments, a stock solution of the flavonoids dissolved in 100% dimethyl sulphoxide (DMSO) at the concentration of 200 mg/ml was further diluted with culture medium prior to administration in cell cultures. For in vivo treatment, Quercetin (100 mg/kg) was first dissolved in 100% DMSO and then diluted with PBS to a final volume of 100 μl/10 g of body weight.
+ Open protocol
+ Expand
6

Transient Transfection and Luciferase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
HEK 293T cells were seeded in a 96‐well plates at 2 × 104 cells/well overnight, and cells were transiently transfected with FuGENE® 6 (Promega) for 24 h for a total of 0.4 μg of DNA consisting of 50 ng TLR plasmids, 200 ng of pBIIXLuc reporter plasmid, 5 ng of control Renilla luciferase (pRL‐null, Promega) and 50 ng of myc‐PumA expression vector. The total amount of DNA was kept constant by adding empty vector. Where indicated, cells were treated with E. coli LPS (1 μg/ml) and Flagellin FLA‐ST (1 μg/ml), all obtained from InvivoGen, for 6 h. In the case of IL‐1β and TNFR, endogenous receptors were stimulated with IL‐1β (100 ng/ml) and TNFα (100 ng/ml), respectively. Cells were then lysed and luciferase activity measured using Dual‐Glo Luciferase Assay System (Promega).
+ Open protocol
+ Expand
7

Transfecting Rainbow Trout Macrophages

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rainbow trout head kidney macrophages were transiently transfected for 12 h using Lipofectamine™ 3000 Transfection Reagent (Life, Shanghai, china), according to the manufacturer’s instructions, with 0.3 μg of DNA, including 50 ng of TLR-4 and TLR-2 plasmids (Miaoling Bioscience & Technology Co., Ltd., Wuhan, China), 200 ng of pBIIXLuc reporter plasmid, and 50 ng of the FLAG-stir-2 expression vector. The total amount of DNA was kept constant by adding empty vector. Where indicated, cells were treated with E. coli LPS (Invivogen) and Pam2CSK4 (Invivogen) for 8 h and lysed. Luciferase activity was measured using the Dual-Glo® Luciferase Assay System (Promega, Beijing, china). The stir-2 sequences from SC09 genomic DNA were ligated into pCMV-Tag 2B using Exnase II (ClonExpress II, Vazyme, Nanjing, china).
+ Open protocol
+ Expand
8

Monocyte cytokine response to TLR ligands

Check if the same lab product or an alternative is used in the 5 most similar protocols
IHMC monocytes were purified using CD14+ Microbeads (Miltenyi) and cultured for 24h in the presence of TLR ligands (TLR2: 108/ml heat-killed Listeria monocytogenes, TLR3: 10 µg/ml polyI:C, TLR4: 1 µg/ml E. coli LPS, TLR5: 1 µg/ml B. subtilis flagellin, TLR8: 5 µg/ml ssRNA40; Invivogen). Supernatants were collected and measured for the accumulation of 12 different cytokines and chemokines using Cytometric Bead Arrays (BD Biosciences).
+ Open protocol
+ Expand
9

Monocyte Cytokine Response to LPS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Isolated monocytes were plated at 1x105 cells/well in 96-well plates in 200 μL of complete culture medium (RPMI 1640 with 10% FBS, 100 U/mL penicillin, 100 μg/mL streptomycin, and 0.29 mg/mL L-glutamine). Monocytes were treated with E. coli LPS (Invivogen) at 100 ng/mL. After 18 hours, the plates were briefly centrifuged, and cell-free supernatant was harvested for analysis. TNFα and IL-6 were measured in culture supernatant by ELISA (R&D Systems) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
10

Adoptive Transfer and Intradermal Challenge

Check if the same lab product or an alternative is used in the 5 most similar protocols

Example 7

A total of 3×105 CFSE-labeled OTI CD8+ T cells are injected into CD45.1+ recipient mice as described above. At 1 and 6 d following adoptive transfer, mice are i.v. administered 100 μL of OVA-comprising erythroid cells into the tail vein. At 15 d following adoptive transfer, mice are challenged with 5 μg of OVA and 25 ng of ultrapure E. coli LPS (InvivoGen) in 25 μL of saline injected intradermally into each rear leg pad (Hock method: total dose of 10 μg of OVA and 50 ng of LPS). Quantification of antigen specific B and T cells and serum antibody titer is described below.

+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!